|
Outcome
|
Control group (n=6)
|
Intervention group (n=6)
|
Risk differencec (Control-intervention) (95 % CI)
|
p-value
|
|---|
|
Primary outcome
|
|
PPH Hb diffa ≥2g/dl (sd)
|
18.5 % (5.9)
|
11.4 % (8.4)
|
7.1 % (-3.1 % to 17.3 %)
|
0.14
|
|
PPH Hb diffb ≥2g/dl (sd)
|
15.0 % (4.3)
|
11.1 % (3.0)
|
3.9 % (-1.5 % to 9.3 %)
|
0.12
|
|
Secondary outcomes
|
|
Postpartum anaemia (sd)
|
43.3 % (10.0)
|
41.3 % (11.0)
|
2.0 % (-2.4 % to 6.4 %)
|
0.30
|
|
Health facility births (sd)
|
87.5 % (7.3)
|
85.4 % (9.3)
|
2.1 % (-1.4 % to 5.6 %)
|
0.19
|
|
Uterotonic use at birth (sd)
|
80.4 % (12.6)
|
91.4 % (7.0)
|
−11.0 % (-25.7 % to 3.6 %)
|
0.11
|
|
Fever & shivering (sd)
|
14.9 % (3.4)
|
22.2 % (5.3)
|
−7.2 % (-11.1 % to -3.7 %)
|
0.005
|
-
PPH postpartum haemorrhage, aHb diff=postpartum haemoglobin - antenatal haemoglobin in women followed within 3rd to 5th day; n=412 in control and n=377 in intervention, bHb difference in all women; n=1140 in control and n=909 in intervention, c risk difference at cluster level are in means, sd standard deviation, CI confidence interval
